Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache
Authors:
- 25 May 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 62 (10) , 1706-1711
Abstract
Background: The tricyclic antidepressant amitriptyline is the only drug with prophylactic efficacy for chronic tension-type headache. However, amitriptyline is only moderately effective, with headache reduction of approximately 30%, and treatment is often hampered by side effects. Mirtazapine is a relatively new so-called noradrenergic and specific serotonergic antidepressant, which is more specific and therefore generally better tolerated. Objective: To evaluate the efficacy of mirtazapine. Methods: Twenty-four nondepressed patients with chronic tension-type headache were included in a randomized, double-blind, placebo-controlled, crossover trial. All patients had tried numerous other treatments. Mirtazapine 15 to 30 mg/day or placebo was each given for 8 weeks separated by a 2-week wash-out period. Results: Twenty-two patients completed the study. The primary efficacy variable, area-under-the-headache curve (AUC; duration × intensity), was lower during treatment with mirtazapine (843) than during treatment with placebo (1,275) (p = 0.01). Mirtazapine also reduced the secondary efficacy variables headache frequency (p = 0.005), headache duration (p = 0.03), and headache intensity (p = 0.03) and was well tolerated. Conclusions: Mirtazapine reduced AUC by 34% more than placebo in difficult-to-treat patients. This finding is clinically relevant and may stimulate the development of prophylactic treatments with increased efficacy and fewer side effects for tension-type headache and other types of chronic pain.Keywords
This publication has 33 references indexed in Scilit:
- Tolerability and safety aspects of mirtazapineHuman Psychopharmacology: Clinical and Experimental, 2002
- A Review of the Pharmacological and Clinical Profile of MirtazapineCNS Drug Reviews, 2001
- The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literatureHarvard Review of Psychiatry, 2000
- Letters to the EditorHeadache: The Journal of Head and Face Pain, 1999
- MirtazapineDrugs, 1999
- The platelet serotonin transporter in primary headachesEuropean Journal of Neurology, 1998
- A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slicesNeuropharmacology, 1993
- Impact of headache on sickness absence and utilisation of medical services: a Danish population study.Journal of Epidemiology and Community Health, 1992
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960